97 related articles for article (PubMed ID: 3094204)
1. Inactivation of human T-cell lymphotropic virus, type III by heat, chemicals, and irradiation.
Quinnan GV; Wells MA; Wittek AE; Phelan MA; Mayner RE; Feinstone S; Purcell RH; Epstein JS
Transfusion; 1986; 26(5):481-3. PubMed ID: 3094204
[TBL] [Abstract][Full Text] [Related]
2. Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor.
McDougal JS; Martin LS; Cort SP; Mozen M; Heldebrant CM; Evatt BL
J Clin Invest; 1985 Aug; 76(2):875-7. PubMed ID: 2993366
[TBL] [Abstract][Full Text] [Related]
3. Heat inactivation of human immunodeficiency virus in solutions of antithrombin III.
Einarsson M; Perenius L; McDougal JS; Cort S
Transfusion; 1989 Feb; 29(2):148-52. PubMed ID: 2919425
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of viruses in labile blood derivatives. II. Physical methods.
Horowitz B; Wiebe ME; Lippin A; Vandersande J; Stryker MH
Transfusion; 1985; 25(6):523-7. PubMed ID: 3934802
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of hepatitis B and non-A, non-B viruses by combined use of Tween 80, beta-propiolactone, and ultraviolet irradiation.
Prince AM; Stephan W; Kotitschke R; Brotman B
Thromb Haemost; 1983 Aug; 50(2):534-6. PubMed ID: 6415846
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of viral safety of a high-purity human factor VIII concentrate submitted to 2 specific virus inactivation treatments (FANDHI)].
Ristol P; Gensana M; Fernández J; Massot M; Biescas H; Darling A; Jorquera JI; Vericat F
Sangre (Barc); 1996 Apr; 41(2):131-6. PubMed ID: 9045353
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assays for evaluation of HTLV-III inactivation procedures: tri(N-butyl)phosphate:sodium cholate and beta-propiolactone.
Prince AM; Horowitz B; Dichtelmueller H; Stephan W; Gallo RC
Cancer Res; 1985 Sep; 45(9 Suppl):4592s-4594s. PubMed ID: 2410108
[TBL] [Abstract][Full Text] [Related]
8. Sterilisation of hepatitis and HTLV-III viruses by exposure to tri(n-butyl)phosphate and sodium cholate.
Prince AM; Horowitz B; Brotman B
Lancet; 1986 Mar; 1(8483):706-10. PubMed ID: 2870224
[TBL] [Abstract][Full Text] [Related]
9. Dry-heat treatment process for enhancing viral safety of an antihemophilic factor VIII concentrate prepared from human plasma.
Kim IS; Choi YW; Kang Y; Sung HM; Shin JS
J Microbiol Biotechnol; 2008 May; 18(5):997-1003. PubMed ID: 18633304
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet light.
Spire B; Dormont D; Barré-Sinoussi F; Montagnier L; Chermann JC
Lancet; 1985 Jan; 1(8422):188-9. PubMed ID: 2857267
[TBL] [Abstract][Full Text] [Related]
11. [Factor VIII:C activity during heat inactivation of viruses in cryoprecipitates].
Grgicević D; Flego I; Marchiotti I; Lupret L; Rajninger-Miholić M
Lijec Vjesn; 1990; 112(7-8):212-5. PubMed ID: 2127297
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of HTLV-III/LAV, hepatitis B and non-A/non-B viruses by pasteurization in human plasma protein preparations.
Mauler R; Merkle W; Hilfenhaus J
Dev Biol Stand; 1987; 67():337-51. PubMed ID: 3111911
[TBL] [Abstract][Full Text] [Related]
13. Thermal inactivation of human immunodeficiency virus in lyophilised blood products evaluated by ID50 titrations.
Tersmette M; de Goede RE; Over J; de Jonge E; Radema H; Lucas CJ; Huisman HG; Miedema F
Vox Sang; 1986; 51(3):239-43. PubMed ID: 3643679
[TBL] [Abstract][Full Text] [Related]
14. Current safety of clotting factor concentrates.
Epstein JS; Fricke WA
Arch Pathol Lab Med; 1990 Mar; 114(3):335-40. PubMed ID: 2407224
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of two viral inactivation methods for the preparation of safer factor VIII and factor IX concentrates.
Heldebrant CM; Gomperts ED; Kasper CK; McDougal JS; Friedman AE; Hwang DS; Muchmore E; Jordan S; Miller R; Sergis-Davenport E
Transfusion; 1985; 25(6):510-5. PubMed ID: 3934800
[TBL] [Abstract][Full Text] [Related]
16. Heat inactivation of human immunodeficiency virus in lyophilized anti-inhibitor coagulant complex (Autoplex).
Piszkiewicz D; Thomas W; Lieu M; Cabradilla CD; Andrews J; Kim J; Bourret E; McDougal JS; Cort SP
Thromb Res; 1986 Dec; 44(5):701-7. PubMed ID: 3492776
[No Abstract] [Full Text] [Related]
17. [Viral inactivation of antihemophilic factors in acquired immunodeficiency syndrome (AIDS)].
Liras A
Sangre (Barc); 1988 Feb; 33(1):34-8. PubMed ID: 3132744
[No Abstract] [Full Text] [Related]
18. Recovery and inactivation of infectious retroviruses from factor VIII concentration.
Levy JA; Mitra G; Mozen MM
Lancet; 1984 Sep; 2(8405):722-3. PubMed ID: 6148474
[TBL] [Abstract][Full Text] [Related]
19. "In vitro" and in animal model studies on a double virus-inactivated factor VIII concentrate.
Arrighi S; Rossi R; Borri MG; Lesnikov V; Lesnikova M; Franco E; Divizia M; De Santis ME; Bucci E
Thromb Haemost; 1995 Sep; 74(3):868-73. PubMed ID: 8571312
[TBL] [Abstract][Full Text] [Related]
20. Sindbis virus as a tool for quality control of viral inactivation of heated and chemically treated plasma-derived products.
Espíndola OM; Belluci MS; Oliveira BC; Liberto MI; Cabral MC
J Virol Methods; 2006 Jun; 134(1-2):171-5. PubMed ID: 16507321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
